Advertisement

Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom's macroglobulinemia

Christine Chen, David Siegel, Martin Gutierrez, Meagan Jacoby, Craig C. Hofmeister, Nashat Gabrail, Rachid Baz, Morten Mau-Sorensen, Jesus G. Berdeja, Michael Savona, Lynn Savoie, Suzanne Trudel, Nuchanan Areethamsirikul, T.J. Unger, Tami Rashal, Tim Hanke, Michael Kauffman, Sharon Shacham and Donna Reece

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted August 7, 2017
  • Accepted November 22, 2017
  • Published online December 4, 2017.

Article Versions


Contributors 
  • Christine Chen, 1 Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre and The University of Toronto, Toronto, ON, Canada;
  • David Siegel, 2 Department of Hematology, John Theurer Cancer Center, Hackensack, NJ, United States;
  • Martin Gutierrez, 2 Department of Hematology, John Theurer Cancer Center, Hackensack, NJ, United States;
  • Meagan Jacoby, 3 Siteman Cancer Center, Washington University in Saint Louis, Saint Louis, MO, United States;
  • Craig C. Hofmeister, 4 Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, United States;
  • Nashat Gabrail, 5 Gabrail Cancer Institute, Canton, OH, United States;
  • Rachid Baz, 6 Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States;
  • Morten Mau-Sorensen, 7 Department of Oncology, Rigshospitalet, Copenhagen, Denmark;
  • Jesus G. Berdeja, 8 Blood Cancer Research Program, Sarah Cannon Research Institute, Nashville, TN, United States;
  • Michael Savona, 9 Division of Hematology & Oncology, Vanderbilt-Ingram Cancer Center/Vanderbilt University Medical Center, Nashville, TN, United States;
  • Lynn Savoie, 10 Tom Baker Cancer Centre Division of Hematology, University of Calgary, Calgary, AB, Canada;
  • Suzanne Trudel, 1 Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre and The University of Toronto, Toronto, ON, Canada;
  • Nuchanan Areethamsirikul, 1 Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre and The University of Toronto, Toronto, ON, Canada;
  • T.J. Unger, 11 Karyopharm Therapeutics Inc, Newton, MA, United States
  • Tami Rashal, 11 Karyopharm Therapeutics Inc, Newton, MA, United States
  • Tim Hanke, 11 Karyopharm Therapeutics Inc, Newton, MA, United States
  • Michael Kauffman, 11 Karyopharm Therapeutics Inc, Newton, MA, United States
  • Sharon Shacham, 11 Karyopharm Therapeutics Inc, Newton, MA, United States
  • Donna Reece, 1 Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre and The University of Toronto, Toronto, ON, Canada;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output